From The Industry Experts
-
Cancer Treatment: Advances In The 20th And 21st Centuries
4/29/2024
This exploration not only illuminates the remarkable strides made in combating cancer but also underscores the pivotal role of cutting-edge technologies in shaping the trajectory of oncological care.
-
6 Decades Of Impact: DIA’s Global Journey
4/29/2024
By embracing its foundational pillars, learn how DIA continues to address ongoing challenges in drug information and healthcare as it enters its seventh decade in the industry.
-
CRO Industry Trends And Challenges
4/29/2024
Kort Schickfus from IQVIA offers insights into the current landscape of R&D trends, outsourcing dynamics, and the essential capabilities required to navigate the intricacies of modern clinical trials.
-
What Can Digital Patient Twins Do For Clinical Research?
4/29/2024
Digital patient twins have the potential to vastly improve our current healthcare systems by offering personalized therapeutics, enhanced health monitoring, and streamlined pharmaceutical manufacturing, including clinical trials.
-
Closing The Gap In Our Understanding Of Sleep Health With DHTs
4/26/2024
This article delves into the current state of sleep assessments in clinical trials, advocates for a broader understanding of sleep, explores opportunities presented by wearable digital health technologies and examines regulatory expectations.
-
The Relevance Of ePROs In Early Phase Clinical Trials
4/26/2024
Examine how integrating electronic Patient Reported Outcomes (ePROs) in early clinical research not only enhances understanding of the drug's effects but also amplifies its market value.
-
Fortifying The 3 Cs With Strategic Approaches And Tools
4/25/2024
In part two of this series, the authors continue the discussion by identifying specific tools and strategies that companies can use to improve communication and collaboration.
-
Assessing The 3Cs: Does Your Organization Have The Foundation For Clinical Trial Success?
4/25/2024
In part one of this series on exploring the importance of culture, communication, and collaboration, the authors discuss the makings of a strong company foundation and offer an assessment plan meant to reveal strengths and weaknesses in those three areas.
-
Empowering Transformation Through Technology
4/24/2024
By outlining the transformation of clinical data management into data science, this paper highlights the growing responsibility of data managers as stewards of all clinical trial data and its overall quality.
-
Validating A Better ALS Biomarker With Coya’s Fred Grossman
4/24/2024
Coya Therapeutics President and CMO Fred Grossman, DO, FAPA discusses a potential new biomarker for ALS — 4-HNE, an oxidative stress biomarker — and how it could be more effective than the current standard, NfL.